Apton Biosystems specializes in advanced sequencing technologies that enhance genomic research through high accuracy and comprehensive data generation. Their HiFi long-read sequencing technology offers remarkable read lengths of up to 25 kb with an accuracy of 99.9%, enabling precise detection of various genomic variants, including single nucleotide and structural variants. This technology is particularly beneficial for addressing complex biological questions, as it combines the advantages of long reads with the reliability typically associated with short-read sequencing. Additionally, the Sequencing by Binding (SBB) technology provides ultra-high accuracy for short-read sequencing, allowing researchers to uncover rare variants and tackle challenging genomic regions effectively.

The company also offers innovative solutions for sample preparation and targeted sequencing. The Kinnex technology enhances throughput for RNA sequencing and microbiome profiling by utilizing the MAS-Seq method, which allows for the concatenation of smaller amplicons into larger libraries. Furthermore, PureTarget employs CRISPR/Cas9 to create targeted native DNA libraries without amplification, preserving epigenetic signals and minimizing errors. The Nanobind DNA extraction technology enables the efficient extraction of high-quality DNA from various sample types, producing longer fragments with minimal input and without harmful chemicals. Collectively, these technologies position Apton Biosystems as a leader in the field of genomics, supporting a wide range of applications from human genomics to microbial and plant research.

United States

Apton is a California-based biotechnology company that manufactures and supplies single-molecule detection and sequencing imaging systems for clinical applications.

Apton Biosystems

Company Details